Insights on Discovery

1. Why The Traditional Approach To Evaluating Gene Editing Is Not Your Only Option 9/7/2026

   De-risk genetic medicine development with a phased evaluation approach. Gain rapid, data-driven feasibility insights before major investments, enabling smarter decisions and faster clinical progress.

2. Robust Database Characterizes And Optimizes Product Development 8/29/2026

   Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

3. CRISPR-Cas9 KO Cell Line Generation And Development 8/24/2026

   See how CRISPR-generated FKRP knockout muscle cells and a high-throughput On-Cell Western method can quantify α-dystroglycan glycosylation restoration and support rAAV-FKRP potency testing.

4. Receptor Occupancy In The Era Of Multispecific Therapeutics 8/21/2026

   Receptor occupancy studies face new challenges as multispecific therapeutics introduce complex target engagement, receptor trafficking, cellular interactions, and assay interpretation considerations.

5. Patient-Derived Organoids For Cell Therapy Development 8/12/2026

   Patient-derived organoids offer a more accurate way to test cell therapies by preserving the complex tumor environments that determine whether these treatments will actually work.

6. Moving Beyond Animal Models With iPSC-Based Models 8/12/2026

   Animal models are giving way to iPSC-based systems that better reflect human biology, offering researchers a more accurate and ethical path to drug discovery.

7. Modeling Neurodegenerative Disorders: Where Are We Now? 8/12/2026

   Neurodegenerative disease research faces a critical gap between symptom management and disease modification, making better preclinical models an urgent priority for the field.

8. From 2D To Organ-On-A-Chip: Platforms Powering Modern Disease Models 8/12/2026

   Disease modeling has evolved well beyond animal studies, and understanding which platform fits which research question is now a critical skill for modern biology teams.

9. Enabling Effective Passive And Active Immune Cell Targeting Strategies 8/10/2026

   Targeted LNPs that bypass the liver and home to the spleen could reshape in vivo CAR T cell manufacturing. See the data behind the approach.

10. Accelerating Cell Therapy Discovery With High-Throughput Electroporation 7/31/2026

    Discover how high-throughput electroporation-based screening can compress your CAR-T optimization timeline while delivering reproducible, scale-ready results across multiple donor samples.